Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
18.22B | 18.13B | 17.51B | 16.79B | 15.85B | 14.15B | Gross Profit |
7.71B | 7.62B | 7.13B | 6.45B | 5.50B | 4.28B | EBIT |
1.45B | 1.32B | 1.25B | 967.00M | 541.00M | -564.00M | EBITDA |
1.80B | 2.10B | 1.62B | 1.24B | 753.00M | -752.00M | Net Income Common Stockholders |
1.56B | 1.37B | 764.00M | 878.00M | 773.00M | -1.20B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
11.67B | 10.65B | 9.51B | 10.35B | 8.78B | 8.30B | Total Assets |
30.03B | 29.96B | 28.70B | 27.32B | 26.67B | 25.22B | Total Debt |
0.00 | 0.00 | 66.00M | 95.00M | 13.00M | 34.00M | Net Debt |
-11.67B | -10.65B | -9.51B | -10.25B | -8.76B | -8.27B | Total Liabilities |
5.27B | 5.35B | 5.15B | 4.91B | 5.43B | 4.96B | Stockholders Equity |
23.86B | 23.68B | 22.67B | 21.58B | 20.45B | 19.51B |
Cash Flow | Free Cash Flow | ||||
0.00 | 1.21B | -2.09B | 784.00M | 343.00M | 77.00M | Operating Cash Flow |
0.00 | 1.32B | 1.09B | 1.16B | 671.00M | 312.00M | Investing Cash Flow |
0.00 | 312.00M | -1.77B | 540.00M | -191.00M | 691.00M | Financing Cash Flow |
0.00 | -458.00M | -454.00M | -266.00M | -214.00M | -252.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | ¥356.29B | 13.72 | 15.34% | 2.62% | 11.77% | 31.94% | |
77 Outperform | $987.65B | 18.46 | 11.39% | 1.57% | 4.12% | -14.50% | |
74 Outperform | ¥12.75B | 9.32 | 2.93% | 6.17% | 67.31% | ||
66 Neutral | $4.44B | 12.08 | 5.34% | 5.82% | 4.17% | -11.81% | |
63 Neutral | $454.81B | 81.46 | 0.91% | 3.44% | -0.27% | -81.00% | |
63 Neutral | $248.13B | 30.92 | 3.45% | 4.14% | -2.63% | -31.26% | |
61 Neutral | ¥762.27B | 17.14 | 4.42% | 2.84% | 7.62% | 8.47% |